Indivior Pharmaceuticals, Inc.
Ownership
Ownership Structure
Who owns Indivior Pharmaceuticals, Inc. (INDV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.7% of the shares are freely tradable; institutional investors hold 107.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 15.85 | 18,709,432 | +0.9 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 6.42 | 7,572,287 | -4.0 | 06/30/2026 |
| Oaktree Capital Management LLC | 5.19 | 6,127,212 | -12.3 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.66 | 5,495,486 | -1.6 | 06/30/2026 |
| State Street Corp | 4.23 | 4,992,071 | +1.8 | 06/30/2026 |
| Two Seas Capital LP | 4.02 | 4,746,510 | +0.0 | 03/31/2026 |
| Fuller & Thaler Asset Management Inc | 3.91 | 4,615,816 | +1.9 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 2.88 | 3,395,702 | -3.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.95 | 7,028,347 | +0.0 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.18 | 3,749,161 | -3.4 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Heidbreder Christian | Chief Scientific Officer | 209,337 | 7,410,530 $ | Jul 10, 2026 | direct |
| Anderson Woodrow D | Chief Accounting Officer | 27,638 | 978,385 $ | Aug 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Anderson Woodrow D | Chief Accounting Officer | Buy | 1,500 | 35.69 | 53,535 |
| Aug 5, 2026 | Anderson Woodrow D | Chief Accounting Officer | Buy | 1,500 | 36.28 | 54,420 |
| Jul 10, 2026 | Heidbreder Christian | Chief Scientific Officer | Sell | 18,586 | 41.14 | 764,628 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.